NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
Condition(s):Immunologic Thrombcytopenic Purpura (ITP) AdultsLast Updated:April 22, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Immunologic Thrombcytopenic Purpura (ITP) AdultsLast Updated:April 22, 2015Completed
Condition(s):Hematopoietic and Lymphoid Cell NeoplasmLast Updated:July 21, 2023Completed
Condition(s):Leg Ulcer; Diabetic Foot; Gangrene; Peripheral Vascular Disease; IschemiaLast Updated:December 15, 2016Unknown status
Condition(s):Amyotrophic Lateral SclerosisLast Updated:January 10, 2019Completed
Condition(s):Recurrent Acute Myeloid LeukemiaLast Updated:June 9, 2022Withdrawn
Condition(s):Fusion Protein Expression; Bone Marrow CellsLast Updated:June 1, 2022Unknown status
Condition(s):Hemophagocytic Lymphohistiocytosis; X-Linked Lymphoproliferative Disorders; Chediak-Higashi Syndrome; Griscelli Syndrome; Immunologic Deficiency Syndromes; Langerhans-Cell HistiocytosisLast Updated:December 28, 2017Completed
Condition(s):Survivorship; Stem Cell Transplant ComplicationsLast Updated:November 16, 2021Not yet recruiting
Condition(s):Acute LeukemiaLast Updated:May 28, 2020Terminated
Condition(s):Hematopoietic Stem Cell Transplantation; TP53Last Updated:September 6, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.